Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg, EL(25)A/06
Teva UK Limited is reporting a minor typographical error on the carton for Lansoprazole Gastro-Resistant Hard Capsules 15mg. There are two instances where the dosage form is stated as “tablets” where it should state “gastro-resistant capsule, hard”.
DMRC reference number
DMRC-34494415
Medicine Details
Lansoprazole Gastro-resistant Hard Capsules 15mg
PL: 10622/0308
Active ingredient: lansoprazole
SNOMED code: 9889911000001104
Manufactured By
Teva UK Limited
Affected Lot Batch Numbers
| Batch No. | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 20429 | 31/03/2026 | 28 | 12/07/2024 |
| 20621 | 31/03/2026 | 28 | 16/07/2024 |
| 20622 | 31/03/2026 | 28 | 11/07/2024 |
| 21023 | 31/03/2026 | 28 | 12/07/2024 |
| 21435 | 31/03/2026 | 28 | 12/07/2024 |
| 21568 | 30/04/2026 | 28 | 09/10/2024 |
| 22625 | 31/05/2026 | 28 | 07/11/2024 |
| 22629 | 30/06/2026 | 28 | 11/12/2024 |
| 22717 | 30/06/2026 | 28 | 17/09/2024 |
| 23307 | 30/06/2026 | 28 | 12/11/2024 |
| 25390 | 31/07/2026 | 28 | 24/12/2024 |
| 25541 | 30/09/2026 | 28 | 21/01/2025 |
Background
Teva UK Limited is reporting a minor typographical error on the carton for Lansoprazole Gastro-Resistant Hard Capsules 15mg. There are two instances where the dosage form is stated as “tablets” where it should state “gastro-resistant capsule, hard” – these are shown circled in red on the diagram below:
Advice for Healthcare Professionals:
There is no risk to product quality because of this issue, therefore the affected batches are not being recalled. Healthcare professionals are advised to reassure patients, if contacted, that the cartons only contain capsules as prescribed and that this is a typographical error.
Advice for Patients:
Patients should continue to take capsules from these batches as prescribed by your healthcare professional. This does not affect the quality of the medicine. The cartons contain capsules as prescribed and this is a printing error. If you have concerns about a medicine you may be using, please contact your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Alternatively, you can report by calling 0800 731 6789 for free, Monday to Friday between 9am and 5pm.
Additional information:
For medical information enquiries please telephone 0207 540 7117 or email medinfo@tevauk.com.
For stock control enquiries telephone 0800 590502 or email Customer.services@tevauk.com.
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document